- Active not recruitingPHASE2
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
This study looks at new medicines, Sunitinib and Temsirolimus, for rare cancers that haven't responded to usual treatments. The aim is to see if these medicines can shrink these specific types of cancer. It's a Phase II study, meaning it's still in the earlier stages of testing.
For: Advanced Rare TumoursCanada - Active not recruitingPHASE3
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
This study looks at new ways to treat a type of cancer called rhabdomyosarcoma. It compares standard chemotherapy with chemotherapy plus a drug called temsirolimus, for patients whose cancer has an average chance of coming back. Researchers want to see if adding temsirolimus helps more.
For: Alveolar Rhabdomyosarcoma · Botryoid-Type Embryonal Rhabdomyosarcoma · Embryonal RhabdomyosarcomaUnited States · Australia · Canada